Mineralys Therapeutics CMO David Malcom Rodman disposes of USD 58,785.3 in common shares - MLYS News | RalliesMineralys Therapeutics CMO David Malcom Rodman disposes of USD 58,785.3 in common shares
M
MLYS• Insider option exercise and share sale
- Mineralys Therapeutics Chief Medical Officer Rodman David Malcom exercised stock options for 2,170 shares at USD 16 on Aug. 10.
- He sold 2,170 shares the same day at USD 27.09.
- Directly held common stock fell to 51,384 shares following the transactions.
- Directly held stock options declined to 13,024 following the exercise.
RIO
•
